Popular Articles

Vote For School Lunch Claims Victory! SNA Marketing Campaign Honored With ASAE Summit Award
The School Nutrition Association"s 2008 National School Lunch Week Campaign, "Vote for School Lunch - Presidential Edition," was honored by the American Society of Association Executives (ASAE) with a 2009 Summit Award. The award will be presented to SNA during the 10th Annual Summit Awards Dinner, September 29, 2009 at the National Building Museum in Washington, DC. Buy arimidex to treat cancer.

QLT Announces 12-month Results From Novartis Sponsored MONT BLANC Study Evaluating Standard-fluence Visudyne(R) Combination Therapy
QLT Inc. (NASDAQ: QLTI; TSX: QLT) announced that twelve-month primary analysis results from the Novartis sponsored Phase II MONT BLANC study were presented on June 14, 2009 during the 17th Congress of the European Society of Ophthalmology in Amsterdam, the Netherlands. MONT BLANC is the European study of the Novartis sponsored SUMMIT clinical trial program which investigates the efficacy and safety of combining Visudyne(R) (Novartis Pharma AG) and Lucentis(R) (Novartis Pharma AG, Genentech Inc.). SUMMIT also includes the DENALI study in the US and Canada and the EVEREST study in Asia. MONT BLANC is a 24-month randomized, double-masked, multicenter trial in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. The purpose of the study is to evaluate whether Visudyne combined with Lucentis is not inferior to Lucentis monotherapy with respect to the mean change from baseline in visual acuity (VA) and to evaluate the proportion of patients with a treatment-free interval of at least three months duration after Month 2. At the Month 12 examination, mean VA in the Visudyne combination therapy group improved 2.5 letters from baseline compared with a 4.4 letter improvement in the Lucentis monotherapy group. In the combination therapy group, 96% of patients had a three-month treatment-free interval, compared with 92% in the Lucentis monotherapy group.

generic viagra online


News of the day
Fertility Prediction Kit Ovu-Trac(R) By OvumOptics Harnesses The Testing Power Of Saliva Testing
Saliva sample testing is fast becoming the diagnostic data collector of choice in a variety of medical testing. Over the past two years, American scientists are turning more to the accuracy of results in saliva sample tests, more than traditional blood and urine tests. Ovu-Trac® is at the leading edge of this scientific knowledge with its ovulation test and predictor kit. These fertility test kits can help women who are trying to conceive a child determine when they are ovulating.

DNA Computation Gets Logical At The Weizmann Institute Of Science.

Biomolecular computers, made of DNA and other biological molecules, only exist today in a few specialized labs, remote from the regular computer user. Nonetheless, Tom Ran and Shai Kaplan, research students in the lab of Prof. Ehud Shapiro of the Weizmann Institute"s Biological Chemistry, and Computer Science and Applied Mathematics Departments have found a way to make these microscopic computing devices "user friendly," even while performing complex computations and answering complicated queries. Shapiro and his team at Weizmann introduced the first autonomous programmable DNA computing device in 2001. So small that a trillion fit in a drop of water, that device was able to perform such simple calculations as checking a list of 0s and 1s to determine if there was an even number of 1s.

New National Study Finds Increase In P.E. Class-Related Injuries.

Physical education (PE) in schools is one of the main tools used to increase physical activity and to prevent childhood obesity, and PE-related injuries are on the rise. Although increasing physical activity may reduce obesity, it may also increase the risk of injury. While recognizing that PE classes and physical activity are important components in combating obesity, parents and school administrators should remain vigilant for injuries. A recent study conducted by the Center for Injury Research and Policy of The Research Institute at Nationwide Children"s Hospital, found that the number of PE-related injuries to elementary, middle and high school students in the United States increased 150 percent between 1997 and 2007. plumbing in toronto

'SIRT'ain Security: The Protein SIRT3 Protects The Heart.

Sirtuin proteins have been shown to promote longevity in many organisms, and increased expression of one sirtuin protein, SIRT3, has been linked to increased human lifespan. New data, generated in mice, by Mahesh Gupta and colleagues, at the University of Chicago, Chicago, has revealed that Sirt3 helps protect the mouse heart. In the study, the heart of mice lacking Sirt3 was found to show signs of becoming enlarged (a process known as cardiac hypertrophy), at about 8 weeks of age. Further, these mice responded dramatically to conditions that induce cardiac hypertrophy, whereas mice overexpressing Sirt3 were protected from cardiac hypertrophy under the same conditions. Additional analysis revealed the mechanism by which Sirt3 blocks the cardiac hypertrophic response, thereby providing protection to the mouse heart. basement mold toronto

Stanford Research Assesses Use Of Tamiflu, Relenza To Prevent Flu.

Two common anti-influenza drugs - Relenza and Tamiflu - appear equally effective at preventing common flu symptoms when given before infection, say researchers from the Stanford University School of Medicine. However, data is lacking on the effectiveness and safety of the two drugs in vulnerable groups such as the very young and people with compromised immune systems. The researchers pooled and analyzed the data from seven previously published studies because countries around the world are stockpiling these and other drugs for possible use in the current H1N1 pandemic, as well as for future influenza pandemics. Their results will be published in the Annals of Internal Medicine on Aug. 4. Together, the studies, published between 1999 and 2007, indicated that individuals treated with either of the drugs were less likely to develop symptomatic influenza (that is, to both test positive for influenza infection in laboratory tests and to experience flu symptoms like fever, headache, muscle aches and coughing) than did those who had received the placebo. Those who received the drugs were, however, no less likely to become infected.